Martin Michaud
YOU?
Author Swipe
View article: French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease Open
Gaucher disease (GD) is a rare autosomal recessive lysosomal disorder caused by glucocerebrosidase deficiency, with a prevalence in France of around 1/130,000 people. The clinical picture of GD is very heterogeneous, ranging from lifelong …
View article: Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc) Open
In SSc, MMF/RTX combination is well-tolerated and improves skin and ILD involvement, particularly when MMF and RTX are introduced simultaneously.
View article: SplenoMegaly study (SMS): exploring the etiologies for “unexplained” splenomegalies in the real world
SplenoMegaly study (SMS): exploring the etiologies for “unexplained” splenomegalies in the real world Open
Background The predominant etiologies of splenomegaly (SM) are readily discernible through routine clinical assessments, yet in numerous instances, the etiological basis remains elusive. Subsequent diagnostic steps are not consensual and a…
View article: Acid sphingomyelinase deficiency in France: a retrospective survival study
Acid sphingomyelinase deficiency in France: a retrospective survival study Open
View article: Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey Open
We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in COVI…
View article: Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study Open
Objectives In this large multicentre study, we compared the effectiveness and safety of tocilizumab intravenous versus subcutaneous (SC) in 109 Takayasu arteritis (TAK) patients. Methods We conducted a retrospective multicentre study in re…
View article: Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases) Open
Objectives To assess the tolerance and efficacy of targeted therapies prescribed off-label in refractory low-prevalence autoimmune and inflammatory systemic diseases. Methods The TATA registry (TArgeted Therapy in Autoimmune Diseases) is a…
View article: Perioperative Doppler ultrasound assessment of portal vein flow pulsatility in high-risk cardiac surgery patients: a multicentre prospective cohort study
Perioperative Doppler ultrasound assessment of portal vein flow pulsatility in high-risk cardiac surgery patients: a multicentre prospective cohort study Open
View article: JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis
JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis Open
Objectives Excessive and inappropriate production of pro-inflammatory cytokines plays a key role in Still’s disease. Janus kinase inhibitor (JAKi) agents mainly block pro-inflammatory cytokine pathways, notably IL-6 and IFN. The objective …
View article: Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality Open
View article: Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study) Open
Background: Few studies of daily practice for patients with giant cell arteritis (GCA) are available. This French study aimed to describe the characteristics and management of GCA in a real-life setting. Methods: Cross-sectional, non-inter…
View article: Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica Open
To the Editor: Glucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR). 1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PM…
View article: Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients Open
Objective To assess the safety and the efficacy of TNF-α antagonists and tocilizumab in patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age 29 years (interquartile range 7–62)], 186 (89%) females] w…
View article: Sine Scleroderma, Limited Cutaneous and Diffused Cutaneous Systemic Sclerosis Survival and Predictors of Mortality
Sine Scleroderma, Limited Cutaneous and Diffused Cutaneous Systemic Sclerosis Survival and Predictors of Mortality Open
Background: Systemic sclerosis (SSc) is associated with a variability of mortality rate in the literature.Objective: To determine the mortality and its predictors in a long-term follow- up of a bi-centric cohort of SSc patients.Methods: A …
View article: Bibliography
Bibliography Open
View article: Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study
Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study Open
Introduction: We aimed to analyze patients with acute and chronic joint involvements in sarcoidosis. Methods: This is a retrospective multicenter analysis of patients with proven sarcoidosis, as defined by clinical, radiological, and histo…
View article: SAT0339 NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC SCLEROSIS: A COHORT STUDY
SAT0339 NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC SCLEROSIS: A COHORT STUDY Open
View article: Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine
Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine Open
View article: FRI0605 EFFECTIVENESS AND SAFETY OF OFF-LABEL USE OF TOCILIZUMAB IN AUTOIMMUNE DISEASES : A MULTICENTER STUDY IN INTERNAL MEDICINE DEPARTMENTS
FRI0605 EFFECTIVENESS AND SAFETY OF OFF-LABEL USE OF TOCILIZUMAB IN AUTOIMMUNE DISEASES : A MULTICENTER STUDY IN INTERNAL MEDICINE DEPARTMENTS Open
View article: Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults Open
View article: OP0241 Efficacy of tocilizumab in takayasu arteritis: multicenter french retrospective study of 46 patients
OP0241 Efficacy of tocilizumab in takayasu arteritis: multicenter french retrospective study of 46 patients Open
View article: Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients Open